Xeris Biopharma Inc.

NASDAQ: XERS · Real-Time Price · USD
7.66
0.36 (4.93%)
At close: Aug 15, 2025, 3:59 PM
7.68
0.26%
After-hours: Aug 15, 2025, 05:18 PM EDT

Xeris Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-54.84M -62.26M -94.66M -94.66M
Depreciation & Amortization
12.63M 13.16M 12.67M 12.67M
Stock-Based Compensation
18.36M 10.72M 12.16M 11.38M
Other Working Capital
10.79M 9.92M -9.99M -9.99M
Other Non-Cash Items
-2.04M -1.1M 3.52M 3.52M
Deferred Income Tax
-2.27M -1.25M -1.42M -1.42M
Change in Working Capital
-8.82M -6.29M -35.15M -35.15M
Operating Cash Flow
-36.98M -47.02M -102.89M -102.89M
Capital Expenditures
-868K -2.26M -524K -524K
Cash Acquisitions
n/a n/a n/a 38.47M
Purchase of Investments
-34.48M -43.74M n/a -43.02M
Sales Maturities Of Investments
40.24M 40M 34.98M 34.98M
Other Investing Acitivies
n/a n/a 34.98M 4.55M
Investing Cash Flow
4.88M -6M 34.46M 34.46M
Debt Repayment
38.17M n/a 102.72M n/a
Common Stock Repurchased
-3.73M -1.01M -468K -534K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.73M -604K -4.78M 781K
Financial Cash Flow
36.17M -1.61M 127.47M 127.47M
Net Cash Flow
4.07M -54.64M 59.04M 59.04M
Free Cash Flow
-37.85M -49.29M -103.42M -103.42M